Loading...
XNZE
GXH
Market cap77mUSD
Nov 13, Last price  
0.93NZD
Name

Green Cross Health Ltd

Chart & Performance

D1W1MN
XNZE:GXH chart
P/E
8.37
P/S
0.26
EPS
0.11
Div Yield, %
5.06%
Shrs. gr., 5y
0.07%
Rev. gr., 5y
-1.63%
Revenues
524m
+3.96%
4,019,000393,00030,000239,00011,413,00016,336,000105,541,00099,204,000248,413,000322,478,000447,700,000487,645,000522,909,000567,236,000568,531,000559,611,000666,628,000492,571,000503,813,000523,752,000
Net income
16m
+35.88%
1,096,000-6,562,000-570,00061,0003,523,0005,161,0009,939,00013,188,00015,034,00014,425,00017,036,00019,642,00016,784,00016,105,00013,490,00016,752,00024,561,00045,234,00011,757,00015,975,000
CFO
53m
+14.54%
000000023,249,00023,246,00021,543,00018,424,00029,918,00033,180,99929,451,00052,514,00069,843,00065,134,00044,456,00045,957,00052,641,000
Dividend
Jun 06, 20240.0235294 NZD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Green Cross Health Limited provides health care and advice services to communities in New Zealand. It operates through Pharmacy Services and Medical Services segments. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores. It operates approximately 345 community pharmacies under the Unichem and Life Pharmacy brands. The Medical Services segment operates owned and equity accounted medical centres; and offers support services provided to its medical centres, as well as medical centres outside the company. It also provides back office and operational services to medical centres; and offers family healthcare services through GP, accident, and medical centres under The Doctors brand. Green Cross Health Limited was incorporated in 1999 and is based in Auckland, New Zealand.
URL
https://www.greencrosshealth.co.nz/
IPO date
Mar 29, 2000
Employees
Domiciled in
NZ
Incorporated in
NZ

Valuation

Title
NZD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT